Glympse Bio raises more than $46M in Series B round for biosensor technology
The company is developing biosensors, initially for NASH, that could be used in place of liver biopsy and have applicability in development of drugs for the disease.
QurAlis raises $42M in Series A round to develop therapies for ALS
Startup companies that have raised closed funding rounds in the past week also include C2N Diagnostics, Carbon Health, Stellar Health and Modulus Discovery.
presented by
5 Major Trends Emerging in Healthcare Benefits in 2025
Employees who enjoy their benefits are more inclined to stay with their company. A 2025 Marsh McLennan Agency report said 73% of employees would remain if plan options were better.